Osaic Holdings’s Y-mAbs Therapeutics YMAB Stock Holding History

Osaic Holdings’s Portfolio YMAB Stock Details YMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4	Closed	-$18	–	8018
2025 Q2	$18	Buy	+4	New	+$18	﹤0.01%	7667
2024 Q3	–	Sell	-30	Closed	-$362	–	7568
2024 Q2	$362	Buy	+30	New	+$405	﹤0.01%	7065
2022 Q4	–	Sell	-1,683	Closed	-$24K	–	7456
2022 Q3	$24K	Buy	+1,683	New	+$27.9K	﹤0.01%	5451
2022 Q1	–	Sell	-4,159	Closed	-$67K	–	7538
2021 Q4	$67K	Buy	+4,159	New	+$88.9K	﹤0.01%	4913
2020 Q4	–	Sell	-200	Closed	-$8K	–	6602
2020 Q3	$8K	Hold	200	–	–	﹤0.01%	5405
2020 Q2	$9K	Buy	+200	New	+$7.56K	﹤0.01%	5246

Other funds holding YMAB

BIG

Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings's YMAB Position: Q3 2025 in Review

Osaic Holdings sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 4 shares — an estimated $18 sold.

Osaic Holdings first reported a position in YMAB in Q2 2020 and held it in 6 quarters. The position peaked at $67K in Q4 2021. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

Osaic Holdings reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
Osaic Holdings sold 4 Y-mAbs Therapeutics shares in Q3 2025, an estimated $18.
Osaic Holdings first reported a position in Y-mAbs Therapeutics in Q2 2020 and held it in 6 quarters.
Osaic Holdings's Y-mAbs Therapeutics position peaked at $67K in Q4 2021.
2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on Osaic Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.